Improving the lives of people suffering from mental illness and substance use disorders

Developing improved pharmaceuticals based on innovative drug delivery technologies

Providing evidence-based digital therapies to improve treatment outcomes

What we do



Commercializing and developing pharmaceuticals addressing large unmet needs

Digital Therapeutics

Digital Therapeutics

Product portfolio of scientifically proven digital therapies

Mental illness & substance use disorders

Mental illness & substance use disorders

Focusing on areas of great human suffering with wider societal implications

We Care

Shedding light on lives affected by addiction and the road to recovery

September 13-19 2021, is the OPIOID AND HEROIN AWARENESS WEEK. In our latest blog, we share a woman´s moving story about how she struggled with addiction until she found the inner strength and right treatment to turn her life around. 

Key News

AUGUST 30, 2021
Synthetic opioids drive record-high surge in fatal overdoses

JULY 16, 2021
Our overdose rescue medication OX124 enters pivotal study

JULY 15, 2021
Announcement of the Q2 2021 Interim Report

Orexo Social

21 September 2021

WE ARE HIRING. #orexo is a pioneer in bringing together traditional LIFE SCIENCE with TECH-knowledge. Join our exci…

17 September 2021

“One day I woke up and the leaves on the tree were a lot greener than they’d ever been” IN OUR LATEST BLOG, Marguer…

16 September 2021

Joseph R Volpicelli Ph.D of Psychiatry visiting @thatsoberguypodcast and among others he talks about how DTx and vo…

Our history

Strong history paving the way for the future. Learn more about our key milestones since we where founded in Uppsala, Sweden, in 1995.

Financial Snapshot

Group net revenues

585 MSEK



-76 MSEK


US Pharma segment EBIT

295 MSEK


Cash position

680 MSEK

Q2 2021

1 Last Twelve Months, Q320-Q221, for more information about financial development Link